SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001040188-20-000077
Filing Date
2020-01-31
Accepted
2020-01-31 10:23:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 cytomx13g_123119.htm SC 13G 39038
  Complete submission text file 0001040188-20-000077.txt   40606
Mailing Address 4900 TIEDEMAN RD BROOKLYN OH 44144
Business Address 4900 TIEDEMAN RD BROOKLYN OH 44144 2168982400
VICTORY CAPITAL MANAGEMENT INC (Filed by) CIK: 0001040188 (see all company filings)

IRS No.: 132700161 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89140 | Film No.: 20563694
SIC: 2834 Pharmaceutical Preparations